The aspects of use of autologous dermal fibroblasts
Abstract
The article dwells on questions of studies of autologous dermal fibroblasts in the cell therapy for the treatment of skin defects. High clinical efficacy and safety of fibroblasts in the treatment of thermal injuries, non-healing wounds, regeneration of tendons and correction of age-related skin changes are shown.
About the Authors
G. A. Apsolihova
The Federal state budgetary scientific institution “Yakut Scientific Center of complex medical problems”
Russian Federation
Russian Federation
Apsolihova Galina Alexandrovna - Junior Researcher, Laboratory of hereditary pathology department of Molecular Genetics of
677007, Yakutsk, ul. Krupskaya, 18
V. A. Alekseev
The Federal state budgetary scientific institution “Yakut Scientific Center of complex medical problems”
Russian Federation
Russian Federation
Alekseev Vladislav Amirovich - Junior Researcher, Laboratory of immunological research department studying adaptation mechanisms
677000, Yakutsk, ul. Kalandarashvili, 38/4 sq. 51
N. I. Pavlova
Federal State Educational Institution of Higher Education “Yakutsk State Agricultural Academy”
Russian Federation
Russian Federation
Pavlova Nadezhda Ivanovna, Graduate
Junior Researcher
677000, Yakutsk, ul. Lisa Chaikinoi, 3, Apt. 6
H. A. Kurtanov
The Federal state budgetary scientific institution “Yakut Scientific Center of complex medical problems”
Russian Federation
Russian Federation
Kurtanov Chariton Alexeevich, MD, PhD, Head of the Laboratory of Hereditary Pathology Department of Molecular Genetics
677027, Yakutsk, street Petrovsky, 32, Apt. 66
References
1. Alekseev A.A. Complex treatment of deep burns on basis of surgical necrectomies and modern biotechnological methods / A.A. Alekseev, K.Z. Salakhiddinov, B.K. Gavrilyuk, Yu.I. Tyurnikov // Annals of surgery. – 2012. – №6. – P.41-45.
2. Zorina A.I. The use of cell technologies in esthetic medicine: current state of the question / A.I. Zorina, V.L. Zorin // Injection methods in cosmetology. – 2016. – №2. – P.56-69.
3. Clinical experience of healing of venous ulcers with the use of a cellular product «The dermal equivalent ED» / I.M. Blinova, N.M. Udintsev, O.I. Aleksandrova, M.F. Ballyuzek [et al.] // Health – the basis of human potential: problems and ways of their decision. – 2015. – №2 (10). – P.690-695.
4. Cell technologies in revitalization of facial skin / V.V. Burunov, N.E. Manturov, G.O. Smirnova [et al.] // Russian Journal of Medicine. – 2009. – №17. – P.1058-1062.
5. Cell technologies in the treatment of radiation burns: experience of Burnasyan Federal Medical Biophysical Centre / K.V. Kotenko, I.I. Eremin, B.B. Moroz [et al.] // Celltransplantology and tissue engineering. – 2012. – №2 (7). – P.97-102.
6. Konstantinova M.V. Skin wounds’ healing basic problems and the use of skin substitutes / M.V. Konstantinova, N.V. Khaytsev, A.A. Kravtsova, L.D. Balashov // Pediatrician. – 2015. -№2. – P.85-95.
7. Krylov K.M. The experience of use of skin equivalent in treatment of 3rd degree burns / K.M. Krylov, D.A. Kozulin, A.V. Panov, M.I. Blinova // III congress of combustiologists of Russia: Collection of abstracts. – 2010. – 174 p.
8. Legon’kova O.A. Modern wound dressings: properties and features / O.A. Legon’kova, A.A. Alekseev // Bulletin of Roszdravnadzor. – 2015. – №6. – P. 66-68.
9. Makeev O.G. Report about three-year clinical research of autologous dermal fibroblasts for correction skin defects / O.G. Makeev, A.I. Ulybin, P.S. Zubanov, E.G. Malishevskaya // Bulletin of the Ural medical academic science. – 2008. – №4. – P. 63-70.
10. Ozyorskaya O.S. Experimental approaches to prove the usage of fibroblast-based cellular compositions indermatocosmetology / O.S. Ozyorskaya, V.V. Shchegolev // Celltransplantology and tissue engineering. – 2008. – №2. – P. 66-67.
11. Sarkisov D.S. Theoretical and practical aspects ofuse of cultivated fibroblasts in restoration of skin integrity / D.S. Sarkisov, A.A. Alekseev // Bulletin of Russian Academy of Medical Science. – 1994. – №7. – P. 6-11.
12. The integrity of injectedautologous human fibroblasts / G. Keller, J. Sebastian, U. Lacombe [et al.] // Bulletin of Experiment. Biol. Medicine. – 2000. – №130 (8). – 203-206.
13. Skin equivalent and method of its production. Patent of the Russian Federation № 2342164. 2006 / N.V. Kalmykova, M.I. Blinov, N.M. Yudintseva [et al.].
14. A multicenter, double-blind, placebocontrolled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles / S.R. Smith, G. Munavalli, R. Weiss [et al.] // Dermatol. Surg. – 2012. – №38. –Р.1234-1243.
15. A phase II randomized vehicle-controlled trial of allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa / S.S. Venugopal, W. Yan, J.W. Frew [et al.] // J Am AcadDermatol, – 2013. -№10. –Р.898-908.
16. Clinical results of an autologous engineered skin / S. Llames, E. Garcia, V. Garcia [et al.] // Cell Tissue Bank. – 2006. – №7. – P. 47–53.
17. Comparison of tissue-engineered and artificial dermis grafts after removal of basal cell carcinoma on face-A pilot study / S.K. Han, S.Y. Kim, R.J. Choi [et al.] // Dermatol. Surg. – 2014. -№40. – Р.460-467.
18. Cultured composite autografts as coverage for an extensive body surface area burn: Case report and review of the technology / D.M. Caruso, W.H. Schuh, M.F. Al-Kasspooles [et al.] // Burns. – 1999. – №25. – P. 771–779.
19. Dhouailly D. Dermo-epidermal interactions between birds and mammals: differentiation of cutaneous appendages / D. Dhouailly // J. Embryol. Exp. Morphol. – 1973. – №30. – Р.587-603.
20. Distinct fibroblast lineages determine dermal architecture in skin development and repair. / R.R. Driskell, B.M. Lichtenberger, E. Hoste [et al.] // Nature. – 2013. – №504. – P.277–281.
21. Fleming K. Denuded congenital lesions: Recessive dystrophic epidermolysis bullosa / K. Fleming [et al.] // Dermatol Online J. – 2009. -№15(4). –Р.4.
22. High prevalence of stump dermatoses 38 years or more after amputation / N.B. Yang, L.A., Garza C.E. Foote [et al.] // Arch. Dermatol. – 2012. – 148. – P.1283–1286.
23. Hong L. Tissue-engineered rabbit cranial suture from autologous fibroblasts and BMP2 / L. Hong, J.J. Mao // J.Dent. Res. – 2004. – №83. – Р.751-756.
24. Intradermal injection of dissociated epidermal cell suspension improves vitiligo / L. Khodadadi, S. Shafieyan, M. Sotoudeh [et al.] // Arch Dermatol Res. – 2010. – №302. –Р.593-599.
25. Karr J.C. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf) / J.C. Karr // Adv. Skin Wound Care. – 2011. -№24. –Р.119-125.
26. Marcelo D.Tissue therapy with autologous dermal and epidermal culture cells for diabetic foot ulcers / D. Marcelo, P.M. Beatriz, R. Jussara, B. Fabiana// Cell Tissue Bank.– 2012. – 13.– Р.241-249.
27. Mesenchymal-epitelial interactions in the skin: aiming for site-specific tissue regeneration / Y. Yamaguchi, V.J. Hearing, S. Itami [et al.] // J. Dermatol. Sci. – 2005. – 40 (1). –Р.1-9.
28. Two-stage implantation of the skin – and bone integrated pylon seeded with autologous fibroblasts induced into osteoblast differentiation for direct skeletal attachment of limb prostheses / M.A. Shevtsov, N.M. Yudintceva, M.T. Blinova [et al.] // Journal of Biomedical Materials Research – Part A. – 2014. – № 9. -Р. 3033-3048.
29. Weiss R.A. Autologous cell therapy: Will it replace dermal fillers? / R.A. Weiss // Fac. Plast. Surg. Clin. N. Am. – 2013. – №21. – Р.299-304.
Review
For citations:
Apsolihova G.A., Alekseev V.A., Pavlova N.I., Kurtanov H.A. The aspects of use of autologous dermal fibroblasts. Yakut Medical Journal. 2016;(4):44-48.
Views:
4
Email this article 